Back

Tafamidis for cardiac amyloidosis.

1 September 2019 (17:15 - 17:32)
Organised by:
Congress Presentation Part of: Success stories in translation from bench to bedside Drugs, Drug Targets ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Claudio Rapezzi

University of Ferrara, Ferrara (Italy)

3 More presentations in this session

Presentation thumbnail
PCSK9 inhibition for cholesterol lowering.
Professor C. Boileau (Paris, FR)
Slides Video
Presentation thumbnail
Prolactin for peripartum cardiomyopathy.
Professor D. Hilfiker-Kleiner (Hannover, DE)
Presentation thumbnail
sGLTII inhibitors for heart failure .
Doctor G. Lopaschuk (Edmonton, CA)
Slides Video

Access the full session

Session thumbnail
Success stories in translation from bench to bedside

The Event

Event poster

ESC Congress 2019

1 September 2019 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
29 June 2021
thumbnail
Congress Session
Amyloidosis – what to look for?
17 May 2025
thumbnail
Congress Presentation
Evolving the understanding of TTR's role in health and disease​
31 August 2025
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources